pennystockhaven
  • Facebook
  • Twitter
  • Youtube
  • Rss
Day-Trading Penny Stocks
  • Home
  • Services
  • Contact Us
Home» Commentary (Page 6)

Aeterna Zentaris (AEZS): Share/Price Target to Over a Buck

Posted on September 21, 2012 by PennyStockHaven in Commentary

We profiled Æterna Zentaris (AEZS) stock as a highly speculative investment opportunity at around $.44.  AEZS shares almost doubled in value for the last six weeks and still on their way to over a dollar. Market favored Æterna’s stock with Roth Capital initiation a  “Buy” share/price target of $1.75 and even more price goal expectations from the […]

Read More

Profited On DARA BioSciences (DARA), Going Long On OXiGENE, Inc. (OXGN)

Posted on September 19, 2012 by PennyStockHaven in Commentary, Stock Market Movers & Losers
OXiGENE logo

DARA BioSciences, Inc. (DARA) stock posted today 20.95% in gains on 6,424,094 shares in trading volume and brought to followers for about 55% in profits since our alert issued on September 13th. Our “gut feeling” and quick observation of DARA’s financials “told” us that a second offering for this biotech penny markets most likely is […]

Read More

KMAG, GTGP, SNMG, TWWI, AERN, ALTO, SRPX and more: SEC’s Order of Suspension of Trading

Posted on September 17, 2012 by PennyStockHaven in Commentary
SEC logo

One simple question to you at first: why even bother to buy & hold OTC’s scam securities that can be halted by SEC at any time? Think… Anyways, here is the list of the 16 stocks that have been suspended for trading on September 17th: AER Energy Resources, Inc. (AERN) is a Nevada corporation based […]

Read More

WPCS International (WPCS): Financial Results for the 1st Quarter of the Fiscal Year 2013

Posted on September 16, 2012 by PennyStockHaven in Commentary
penny stock WPCS logo

WPCS International Incorporated (NASDAQ: WPCS) announced financial results for the fiscal year 2013 first quarter ended July 31, 2012 on Friday, September 14th, after market hours. Highlights: EBITDA of approximately $695,000 compared to an EBITDA loss of $7.1 million in preceding quarter ended April 30, 2012. Net income of approximately $994,000 or $0.14 per diluted […]

Read More

Generex Biotechnology Corporation (GNBT): Trading Alert

Posted on September 14, 2012 by PennyStockHaven in Commentary, Stock Market News
GNBT penny stock trading alert

Generex Biotechnology Corporation (GNBT) announced today presentation of early results from an efficacy study of an immunotherapeutic in triple negative breast cancer patients from its wholly owned subsidiary, Antigen Express, Inc. The results will be made at the 2012 ASCO (American Society of Clinical Oncology) Breast Cancer Symposium on September 14th. Dr. Elizabeth Mittendorf, the […]

Read More

DARA BioSciences (DARA): Granted Exclusive U.S. Commercial Rights to Gelclair®

Posted on September 13, 2012 by PennyStockHaven in Commentary, Stock Market News
Penny markets DARA BioSciences logo

DARA BioSciences, Inc. (DARA) announced today that company entered into an exclusive agreement with The Helsinn Group of Switzerland for U.S. commercial rights to Gelclair®. DARA plans to launch Gelclair, FDA-cleared product indicated for the treatment of oral mucositis, in the first quarter of 2013. Oral mucositis market is approximately 400,000 patients annually according to […]

Read More

Houston American Energy Corp. (HUSA): Unusual Volume Alert

Posted on September 12, 2012 by PennyStockHaven in Commentary, Stock Market Movers & Losers
NYSE penny stock HUSA logo

Houston American Energy Corp. (NYSE: HUSA) shares ended a trading session with gains of over 29% and closed at the high of the day. HUSA has posted on the Company’s web site presentation slides reflecting site, seismic and geological data with respect to its holdings in the Serrania area in Colombia. Sophisticated investors were curious […]

Read More

Peregrine Pharmaceuticals (PPHM): Share Price Correction on the Way

Posted on September 9, 2012 by PennyStockHaven in Commentary
penny biotech stock PPHM

By Mr. BiotechIll, Guest Author Shares of Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) gain almost half their value after announcement that interim results were presented from its 121 patient randomized, double-blind, placebo-controlled Phase IIb trial in patients with refractory non-small cell lung cancer (NSCLC). At glance: Data show statistically significant improvement in overall survival for patients receiving […]

Read More

Quiksilver Inc. (ZQK): Third Quarter Profit Topped Estimates

Posted on September 7, 2012 by PennyStockHaven in Commentary, Stock Market Movers & Losers

Quiksilver Inc.’s (NYSE: ZQK) shares jumped today after the clothing company reported a third-quarter profit that topped estimates: Americas revenue increased 10% to $286.1 million from $260.2 million, and was up 12% in constant currency. Europe revenue decreased 13% to $154.1 million from $176.4 million, and was up modestly in constant currency. Asia Pacific revenue […]

Read More

Office Depot Inc. (ODP): Affirmed Full-Year 2012 Outlook

Posted on September 5, 2012 by PennyStockHaven in Commentary, Stock Market News

Office Depot Inc. (NYSE: ODP) shares gained 12% as of 11 AM EDT regardless of the “south” trading direction in overall retail sector. The office-supplies chain left unchanged its full-year 2012 outlook at a Goldman Sacks Global Retailing Conference: The Company expects to achieve full-year 2012 adjusted EBIT in the $125 to $135 million range, […]

Read More
  • «
  • ‹
  • 4
  • 5
  • 6
  • 7
  • 8
  • ›
  • »

Site

  • Home
  • Services
  • Contact Us
  • About Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Publishers

Financial Network

Yahoo Finance
Reuters
The Motley Fool
WSJ
CNBC
Business Week
The Street
Bloomberg

psh sloganYour Everything Penny Stocks Resource



Copyright © 2021 PennyStockHaven.com. All Rights Reserved